Abstract It is currently understood that osteoarthritis (OA) is a major chronic inflammatory musculoskeletal disease
Professional Consultations Our physicians then provide detailed consultations reviewing health history, lab results, and symptoms to create customized plans to: Normalize hormone levels Relieve deficiency signs Reduce future health risks Enhance patient goals - energy, muscle, sex drive We offer a variety of options for improving men's health
Jumping straight to the most aggressive options (stopping the medication or demanding a dose reduction) before trying basic management strategies means potentially giving up significant health benefits for a problem that had a simple solution
The goal of CMIRPS is to reduce and prevent harmful medication incidents in Canada
Commonly cited ranges run 200500 mcg per dose, once or twice daily, in cycles of 46 weeks
Quick Takeaways Human sleep trials used 25 nmol/kg IV for 7 consecutive nights The commonly used 100250 mcg subcutaneous protocol lacks direct clinical validation DSIP demonstrates an unusually wide safety margin in animal and human research Most evidence comes from small 1980s pilot studies, not modern RCTs What DSIP Actually Is (And Why Its Misunderstood) DSIP is a nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of sleeping rabbits